Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
12,374 datasets
Yasuyuki Takai's dataset contains longitudinal visual acuity data for a cohort of patients with Leber hereditary optic neuropathy (LHON). It includes best-corrected visual acuity (BCVA, logMAR) measurements from onset to 120 months for 53 eyes from 27 patients, collected in a single-center retrospective study at a tertiary eye hospital in Japan. The data was last updated on 2026-04-28.
Yasuyuki Takai's dataset contains longitudinal visual acuity data for a cohort of Japanese patients with Leber hereditary optic neuropathy (LHON). The data includes best-corrected visual acuity (BCVA) measurements from onset to 120 months for 27 patients (53 eyes) who were followed continuously for at least 10 years. The dataset was last updated on April 28, 2026.
Exome data analysis identifies ultra-rare heterozygous variants in TLR9, TNFRSF1B, and FAS genes in Ménière’s disease patients. The dataset includes results from protein modelling, receptor-ligand docking, and splicing predictions. It was authored by Pablo Cruz-Granados and last updated on 2026-05-15.
Pablo Cruz-Granados uploaded this dataset to figshare on May 15, 2026. It contains analysis results from a study investigating ultra-rare heterozygous variants in TLR9, TNFRSF1B, and FAS genes in Ménière’s disease patients. The dataset includes findings from protein modelling, receptor-ligand docking, and splicing predictions.
1,153 patient records from a reproductive medicine center between March 2020 and May 2022 were analyzed in a retrospective study. The data examines the association between basal luteinising hormone levels and clinical pregnancy and live birth rates following fresh embryo transfer, stratified by patient age. The dataset was authored by Mengying Zhang and is shared under a CC-BY-4.0 license.
A retrospective cohort study of 1,176 adults with type 2 diabetes undergoing percutaneous coronary intervention after acute myocardial infarction, conducted between January 1, 2019, and December 31, 2023. The data, authored by Xi He and shared on figshare, investigates the association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and major adverse cardiovascular events over a follow-up period averaging 21.0 ± 6.6 months.
A figshare-hosted document details a phase I/II clinical trial evaluating the combination of durvalumab and tremelimumab in pediatric patients with advanced solid tumors. The study, authored by Darren Hargrave, includes results from 50 total patients across dose-finding and dose-expansion phases, assessing safety, pharmacokinetics, and antitumor activity. The document was last updated in May 2026.
Data Sheet 1 contains data from a hospital-based observational study of 270 consecutive patients hospitalized at the Second Affiliated Hospital of Wannan Medical University between August 2023 and December 2025. The dataset was created by Xuli Chen to investigate the association between the BNP/LVEF biomarker ratio and atrial fibrillation. It includes patient-level data likely containing biomarker measurements, cardiac phenotypes, and AF diagnosis status.
46 patient cases from a kidney transplantation cohort underwent functional magnetic resonance imaging (fMRI) and protocol renal biopsy at 3 or 12 months post-transplantation. The dataset, published on figshare, compares imaging parameters between 17 subclinical rejection cases and 29 normal cases. It includes results from blood oxygenation level-dependent, intravoxel incoherent motion, and diffusion kurtosis imaging analyses.
106 patients with stage I-III breast cancer receiving neoadjuvant chemotherapy (NAC) were monitored with ultrasound imaging at weeks 0, 1, 4, 8, 12, and 16. The dataset, authored by Erika Z. Chung and last updated in 2026, contains patient and treatment characteristics, with tumor size changes evaluated as predictors of final pathological response categorized as Complete, Partial, Weak, or Non-Responder.
Chioma Ubah's dataset contains research information from 427 women of child-bearing age in Obudu Local Government Area, Cross River State, Nigeria. The data includes socio-demographic characteristics, usage of skilled birth attendants and facility-based delivery, and perceptions of health service quality. It was last updated on 2026-05 31 and is shared under a CC-BY-4.0 license.
1,172 patient records from the international, multicentre Recurrence After Whipple (RAW) study analyze the impact of preoperative jaundice management on survival and complications. Data was collected retrospectively for patients with pancreatic head, ampullary, or distal bile duct cancer who underwent pancreaticoduodenectomy. The supplementary material, last updated in May 2026, is shared under a CC-BY-4.0 license by a figshare administrator.
A research article investigating the role of the p62 protein in cardiac physiology under hypoxic conditions. The study uses murine models and H9c2 cardiomyoblasts to examine p62's impact on Hif-1α and Nrf2 signaling pathways. The author is Rajeshwary Ghosh, and the file was last updated on 2026-05-27.
A single case report details a 45-year-old woman with intravenous leiomyomatosis (IVL) presenting as a cardiac mass. The report, authored by Haoxuan Deng and published on figshare under CC-BY-4.0, includes multimodal imaging and histopathological findings. Only short-term postoperative imaging data are available, with long-term follow-up ongoing.
A 2026 study describes CZL-149, a novel dual inhibitor targeting BET and p300/CBP bromodomains. The dataset likely contains potency metrics, such as an IC50 of 3.3 nM against OPM-2 cells, and pharmacokinetic data, including 107% oral bioavailability in mice. The data was uploaded by Zonglong Chen to figshare.
A dataset describes the discovery of CZL-149, a novel dual inhibitor targeting BET and p300/CBP bromodomains. The data includes structural information (PDB files) and preclinical results showing an IC50 of 3.3 nM against OPM-2 cells, 107% oral bioavailability in mice, and 78% tumor growth inhibition. The dataset was authored by Zonglong Chen and last updated on 2026-05-18.
A single-centre retrospective study analysed 189 patients with unexplained recurrent pregnancy loss (URPL) and 91 healthy pregnant women. The dataset likely contains measurements of serum miR-155 expression, Th17 and Treg cell counts, and related cytokines to explore their association with adverse pregnancy outcomes. The study was authored by Yingqiong Chen and last updated on 2026-05-19.
A retrospective study comparing second-line therapies for unresectable hepatocellular carcinoma (uHCC) after first-line atezolizumab plus bevacizumab. The dataset contains real-world data from 81 patients, with 14 receiving durvalumab plus tremelimumab and 67 receiving lenvatinib. It was authored by Chinatsu Nishioka and last updated in May 2026.
81 patient records from a retrospective study comparing second-line therapies for unresectable hepatocellular carcinoma. The dataset, authored by Chinatsu Nishioka and last updated in May 2026, contains real-world data from patients who received either durvalumab plus tremelimumab (n=14) or lenvatinib (n=67) after first-line atezolizumab plus bevacizumab.
A 9.5 KB Excel file containing retrospective real-world data comparing second-line therapies for unresectable hepatocellular carcinoma. The dataset, authored by Chinatsu Nishioka and last updated in May 2026, includes results from a non-randomized comparative study of 81 patients treated with either durvalumab plus tremelimumab or lenvatinib after first-line atezolizumab plus bevacizumab.